pmid,doi,publicationTitle,year,journal,novel_animal_models,novel_antibodies,novel_cell_lines,novel_genetic_reagents,novel_computational_tools,novel_advanced_cellular_models,novel_patient_derived_models,novel_clinical_assessment_tools,existing_tools,total_novel_tools,nf_specific_count,max_priority,tool_usage_publications
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,2020,Cancer research,,,ST88-14; NF96.2; NF94.3; STS26T; JH-2-002; JH-2-031; H1838; WM3918; M308; NF90-8; NF10.1; NF11.1; JH-2–009; JH-2–055; JH-2–060; JH-2–074; JH-2–077,,,,JH-2-002; JH-2-031; NF90.8,,,20,19,High,"PMID:18367665 (cell_line: NF90-8, ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14, STS26T) | PMID:20049725 (cell_line: ST88-14, STS26T) | PMID:23535903 (cell_line: ST88-14, STS26T) | PMID:23685747 (cell_line: ST88-14, STS26T) | PMID:24040940 (cell_line: NF94.3, NF96.2) | PMID:24681606 (cell_line: ST88-14, STS26T) | PMID:24824755 (cell_line: ST88-14) | PMID:32642733 (cell_line: ST88-14, STS26T) | PMID:33032988 (cell_line: H1838, JH-2-002, JH-2-031, JH-2–009, JH-2–055, JH-2–060, JH-2–074, JH-2–077, M308, NF10.1, NF11.1, NF90-8, NF94.3, NF96.2, ST88-14, STS26T, WM3918; patient_derived_model: JH-2-002, JH-2-031, NF90.8) | PMID:33658640 (cell_line: NF90-8, ST88-14) | PMID:35511749 (cell_line: STS26T) | PMID:36322658 (cell_line: STS26T) | PMID:37164978 (cell_line: STS26T) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: STS26T) | PMID:38000020 (cell_line: JH-2-002, JH-2-031; patient_derived_model: JH-2-002, JH-2-031) | PMID:38127282 (cell_line: JH-2-002, ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14, STS26T) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41022755 (cell_line: ST88-14; patient_derived_model: JH-2-002, JH-2-031) | PMID:41036607 (cell_line: ST88-14)"
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,2025,Molecular oncology,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40; P{ KK101909 }VIE‐260B,NF1; Drosophila neurofibromin; human neurofibromin,"ST88-14; ipNF95.11bC; ipnNF95.11c; Drosophila Schneider (S2R+) cells; dNF1‐KO; hTERT ipn02.3 2λ CRL‐3392; ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73); ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)",dNf1,,,,,,14,12,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:20049725 (cell_line: ST88-14) | PMID:23535903 (cell_line: ST88-14) | PMID:23685747 (cell_line: ST88-14) | PMID:24681606 (cell_line: ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:30479396 (antibody: NF1) | PMID:32642733 (cell_line: ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33658640 (cell_line: ST88-14, ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:35741605 (cell_line: ipNF95.11bC, ipnNF95.11c) | PMID:36689660 (cell_line: ipNF95.11bC) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38136356 (cell_line: ipnNF95.11c) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:38714355 (antibody: NF1) | PMID:39061138 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC) | PMID:39129390 (animal_model: P{ KK101909 }VIE‐260B, P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40, y [1] sc[*] v [1] sev [21]; antibody: Drosophila neurofibromin, NF1, human neurofibromin; cell_line: Drosophila Schneider (S2R+) cells, ST88-14, dNF1‐KO, hTERT ipn02.3 2λ CRL‐3392, ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC, ipnNF09.4 (hTERT NF1 ipnNF09.4, RRID: CVCL_UI73), ipnNF95.11c; genetic_reagent: dNf1) | PMID:39269317 (cell_line: ST88-14) | PMID:39472976 (antibody: NF1) | PMID:40723243 (cell_line: ipNF95.11bC, ipnNF95.11c) | PMID:40862755 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC) | PMID:41022755 (antibody: NF1; cell_line: ST88-14) | PMID:41036607 (cell_line: ST88-14) | PMID:41564118 (antibody: NF1)"
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,2025,Nature communications,,NF1,"ST88-14; S462; pNF9511bc; ipNF03.3; ipn023λ; RHT92; LN229; 2V6.11; FiPS; NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12; 3PNF_SiPSsv_MM_11",,,,JH-2-002; JH-2-031,,,14,11,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: S462, ST88-14) | PMID:20049725 (cell_line: S462, ST88-14) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, ST88-14) | PMID:23685747 (cell_line: S462, ST88-14) | PMID:24681606 (cell_line: S462, ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:30055648 (cell_line: S462) | PMID:30479396 (antibody: NF1) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, ST88-14) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: ST88-14; patient_derived_model: JH-2-002, JH-2-031) | PMID:33658640 (cell_line: S462, ST88-14) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:35511749 (cell_line: S462) | PMID:37164978 (cell_line: S462) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462) | PMID:38000020 (patient_derived_model: JH-2-002, JH-2-031) | PMID:38127282 (cell_line: S462, ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:38714355 (antibody: NF1; cell_line: LN229) | PMID:39129390 (antibody: NF1; cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:39472976 (antibody: NF1) | PMID:41001593 (cell_line: S462) | PMID:41022755 (antibody: NF1; cell_line: 2V6.11, 3PNF_SiPSsv_MM_11, FiPS, LN229, NF1−/−−/− edited FiPS Ctrl1-SV4F-7, D12, RHT92, S462, ST88-14, ipNF03.3, ipn023λ, pNF9511bc; patient_derived_model: JH-2-002, JH-2-031) | PMID:41036607 (cell_line: ST88-14) | PMID:41564118 (antibody: NF1)"
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,2023,Science advances,,,JH-2-002; JH-2-031; JH-2-079c; JH-2-103,NF1-GRD,,,JH-2-002; JH-2-031; JH-2-079c PDX; WU-225 PDX; WU-386 PDX; WU-545 PDX; MN-2 PDX; MN-3-002 PDX,,,13,13,High,"PMID:16835260 (genetic_reagent: NF1-GRD) | PMID:24509877 (genetic_reagent: NF1-GRD) | PMID:33032988 (cell_line: JH-2-002, JH-2-031; patient_derived_model: JH-2-002, JH-2-031) | PMID:35393510 (genetic_reagent: NF1-GRD) | PMID:38000020 (cell_line: JH-2-002, JH-2-031, JH-2-079c, JH-2-103; genetic_reagent: NF1-GRD; patient_derived_model: JH-2-002, JH-2-031, JH-2-079c PDX, MN-2 PDX, MN-3-002 PDX, WU-225 PDX, WU-386 PDX, WU-545 PDX) | PMID:38127282 (cell_line: JH-2-002, JH-2-103) | PMID:41022755 (patient_derived_model: JH-2-002, JH-2-031)"
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,2024,Molecular cancer therapeutics,,NF1,LN229; HSR-GBM1; JHH-520 cell line; JHU-0879; JHU-1016B; JHH-136; B76; NGT-41; NMCG-1; DBTRG; T98G,,,,,,,12,10,High,"PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:30479396 (antibody: NF1) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:38714355 (antibody: NF1; cell_line: B76, DBTRG, HSR-GBM1, JHH-136, JHH-520 cell line, JHU-0879, JHU-1016B, LN229, NGT-41, NMCG-1, T98G) | PMID:39129390 (antibody: NF1) | PMID:39472976 (antibody: NF1; cell_line: JHH-520 cell line) | PMID:41022755 (antibody: NF1; cell_line: LN229) | PMID:41564118 (antibody: NF1)"
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,2022,Molecular cancer therapeutics,,,S462; SNF96.2; STS26T; MPNST-SP-01; MPNST-NF1-08; MPNST-NF1-9; HS-PSS; HS-Sch-2; Human Foreskin Fibroblast (HFF),,,,MPNST-SP-01 PDOX; MPNST-NF1-09 PDOX,,,11,6,High,"PMID:18483311 (cell_line: S462, STS26T) | PMID:20049725 (cell_line: S462, STS26T) | PMID:23175151 (cell_line: SNF96.2) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, STS26T) | PMID:23685747 (cell_line: S462, STS26T) | PMID:24681606 (cell_line: S462, STS26T) | PMID:29438698 (cell_line: SNF96.2) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: HS-Sch-2, S462, SNF96.2, STS26T) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: STS26T) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: HS-PSS, HS-Sch-2, Human Foreskin Fibroblast (HFF), MPNST-NF1-08, MPNST-NF1-9, MPNST-SP-01, S462, SNF96.2, STS26T; patient_derived_model: MPNST-NF1-09 PDOX, MPNST-SP-01 PDOX) | PMID:36322658 (cell_line: SNF96.2, STS26T) | PMID:37164978 (cell_line: S462, STS26T) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462) | PMID:38203448 (cell_line: STS26T) | PMID:38216572 (cell_line: SNF96.2) | PMID:38502231 (cell_line: S462) | PMID:39269317 (cell_line: SNF96.2) | PMID:40025578 (cell_line: SNF96.2) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462)"
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,2026,PloS one,,NF1,icNF97.2a; icNF97.2b; icNF98.4d; icNF98.4c; icNF00.10a; icNF04.9a; i28cNF; i18cNF; i21cNF,,,,,,,10,10,High,"PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:30479396 (antibody: NF1) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:38714355 (antibody: NF1) | PMID:38907342 (cell_line: icNF97.2a, icNF97.2b, icNF98.4d) | PMID:39129390 (antibody: NF1) | PMID:39472976 (antibody: NF1) | PMID:41022755 (antibody: NF1) | PMID:41564118 (antibody: NF1; cell_line: i18cNF, i21cNF, i28cNF, icNF00.10a, icNF04.9a, icNF97.2a, icNF97.2b, icNF98.4c, icNF98.4d)"
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,2008,Molecular cancer therapeutics,,,ST88-14; 90-8; S462; STS26T; S520; YST1; ST88-3; T265p21; DS-red STS26T cell line,,,,,,,9,7,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: 90-8, DS-red STS26T cell line, S462, S520, ST88-14, ST88-3, STS26T, T265p21, YST1) | PMID:20049725 (cell_line: 90-8, S462, S520, ST88-14, STS26T, YST1) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, ST88-14, STS26T) | PMID:23685747 (cell_line: S462, ST88-14, STS26T) | PMID:24681606 (cell_line: S462, ST88-14, STS26T) | PMID:24824755 (cell_line: 90-8, ST88-14) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: 90-8, S462, ST88-14, STS26T) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: ST88-14, STS26T) | PMID:33658640 (cell_line: S462, ST88-14) | PMID:35511749 (cell_line: S462, STS26T) | PMID:36322658 (cell_line: STS26T) | PMID:37164978 (cell_line: S462, STS26T) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462, ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14, STS26T) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,2021,British journal of cancer,Nf1flox/flox;PostnCre; Nf1-Arf flox/flox ;Postn-Cre,,"ST88-14; S462; ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71); NF90-8; 95.6; ipn02.3",,,,RHT-92,,,9,8,High,"PMID:18367665 (cell_line: NF90-8, ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: S462, ST88-14) | PMID:19191334 (animal_model: Nf1flox/flox) | PMID:20049725 (cell_line: S462, ST88-14) | PMID:20200958 (animal_model: Nf1flox/flox) | PMID:21439418 (animal_model: Nf1flox/flox) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, ST88-14) | PMID:23685747 (cell_line: S462, ST88-14) | PMID:24681606 (cell_line: S462, ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:25535838 (animal_model: Nf1flox/flox) | PMID:25772366 (animal_model: Nf1flox/flox) | PMID:28525381 (animal_model: Nf1flox/flox) | PMID:29787563 (animal_model: Nf1flox/flox) | PMID:29847659 (animal_model: Nf1flox/flox) | PMID:30055648 (cell_line: S462) | PMID:31527226 (animal_model: Postn-Cre, PostnCre) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, ST88-14) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: NF90-8, ST88-14) | PMID:33442015 (animal_model: Postn-Cre, PostnCre) | PMID:33658640 (animal_model: Nf1-Arf flox/flox, Postn-Cre, PostnCre; cell_line: 95.6, NF90-8, S462, ST88-14, ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipn02.3; patient_derived_model: RHT-92) | PMID:34935315 (animal_model: Nf1flox/flox) | PMID:35511749 (cell_line: S462) | PMID:36890585 (animal_model: Nf1flox/flox) | PMID:37164978 (cell_line: S462) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462) | PMID:38127282 (animal_model: Postn-Cre, PostnCre; cell_line: S462, ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39061138 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)) | PMID:39129390 (cell_line: ST88-14, ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)) | PMID:39269317 (cell_line: ST88-14) | PMID:40684195 (animal_model: Nf1flox/flox) | PMID:40862755 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,Nf1flox/flox;PostnCre; DhhCre; Nf1flox/flox;Arf flox/flox;PostnCre+,,ST88-14; S462; JH-2-002; JH-2-103; hTERT ipn02.3 2λ; hTERT NF1 ipNF95.6 cell line,,,,,,,9,8,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: S462, ST88-14) | PMID:19191334 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:20049725 (cell_line: S462, ST88-14) | PMID:20200958 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:21439418 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, ST88-14) | PMID:23685747 (cell_line: S462, ST88-14) | PMID:24681606 (cell_line: S462, ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:25535838 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:25772366 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:28525381 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:29787563 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:29847659 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:30055648 (cell_line: S462) | PMID:31527226 (animal_model: PostnCre, PostnCre+) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, ST88-14) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: JH-2-002, ST88-14) | PMID:33442015 (animal_model: PostnCre, PostnCre+) | PMID:33658640 (animal_model: PostnCre, PostnCre+; cell_line: S462, ST88-14) | PMID:34935315 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:35511749 (cell_line: S462) | PMID:36322658 (animal_model: DhhCre) | PMID:36890585 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:37140985 (cell_line: hTERT ipn02.3 2λ) | PMID:37164978 (cell_line: S462) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462) | PMID:38000020 (cell_line: JH-2-002, JH-2-103) | PMID:38127282 (animal_model: Arf flox/flox, PostnCre, PostnCre+; cell_line: JH-2-002, JH-2-103, S462, ST88-14, hTERT NF1 ipNF95.6 cell line, hTERT ipn02.3 2λ) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:40684195 (animal_model: Nf1flox/flox, Nf1flox/flox) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,2024,Nature communications,,NF2/merlin,ST88-14; SNF96.2; SNF02.2; NF95.11b; NF95.6; SNF94.3; JW18.2; JW23.3,,,,,,,9,9,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:19144871 (antibody: NF2/merlin) | PMID:20049725 (cell_line: ST88-14) | PMID:23175151 (cell_line: SNF96.2) | PMID:23535903 (cell_line: ST88-14) | PMID:23685747 (cell_line: ST88-14) | PMID:24681606 (cell_line: ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:29438698 (cell_line: SNF02.2, SNF96.2) | PMID:32642733 (cell_line: SNF96.2, ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33273014 (antibody: NF2/merlin) | PMID:33658640 (cell_line: ST88-14) | PMID:35511749 (cell_line: SNF96.2) | PMID:36322658 (cell_line: SNF96.2) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (antibody: NF2/merlin; cell_line: JW18.2, JW23.3, NF95.11b, NF95.6, SNF02.2, SNF94.3, SNF96.2, ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: SNF96.2, ST88-14) | PMID:40025578 (cell_line: SNF96.2) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,2024,Clinical cancer research : an official journal of the American Association for Cancer Research,,,HEK293T cells; ST88-14; M724; SNF96.2; M1; M3; M4; M5; M6,,,,,,,9,8,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:20049725 (cell_line: ST88-14) | PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells, SNF96.2) | PMID:23535903 (cell_line: ST88-14) | PMID:23685747 (cell_line: ST88-14) | PMID:24681606 (cell_line: ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:29438698 (cell_line: SNF96.2) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:32642733 (cell_line: SNF96.2, ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33658640 (cell_line: ST88-14) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35511749 (cell_line: SNF96.2) | PMID:35789380 (cell_line: HEK293T cells, M1, M3, M4, M6) | PMID:36322658 (cell_line: SNF96.2) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: SNF96.2, ST88-14) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: HEK293T cells, M1, M3, M4, M5, M6, M724, SNF96.2, ST88-14) | PMID:40025578 (cell_line: SNF96.2) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,2017,Oncotarget,Nf1 flox/flox; Nf1flox/mut;GFAP-Cre; Nf1flox/wt; Nf1flox/mut; Nf1flox/flox; Olig2-Cre; Nf1flox/mut; Olig2-Cre; Nf1flox/flox; Prom1-CreER; Nf1flox/mut; Prom1-CreER,,,,,,,,Nf1+/-,8,8,High,"PMID:19191334 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:20554030 (animal_model: Nf1flox/mut, Nf1flox/mut, Nf1flox/mut, Nf1flox/mut) | PMID:21439418 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:25535838 (animal_model: GFAP-Cre, Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox, Nf1flox/wt, Olig2-Cre, Olig2-Cre, Prom1-CreER, Prom1-CreER) | PMID:29787563 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox, Nf1flox/flox, Nf1flox/flox)"
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,2018,PloS one,,Merlin; NF2; phospho S518-Merlin,OLN93 mouse oligodendrocyte cell line; SC4-immortalized Nf2-/- primary Schwann cells; RT4-D6PT2 schwannoma cell line; TC620 human oligodendroglioma cell line,NF2,,,,,,8,5,High,"PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin) | PMID:24595234 (antibody: Merlin; genetic_reagent: NF2) | PMID:26219339 (antibody: NF2; genetic_reagent: NF2) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin, NF2, phospho S518-Merlin; cell_line: OLN93 mouse oligodendrocyte cell line, RT4-D6PT2 schwannoma cell line, SC4-immortalized Nf2-/- primary Schwann cells, TC620 human oligodendroglioma cell line; genetic_reagent: NF2) | PMID:30274821 (antibody: Merlin; genetic_reagent: NF2) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:33273014 (genetic_reagent: NF2) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (antibody: Merlin)"
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,2009,EMBO molecular medicine,,,ST88-14; 90-8; S462; STS26T; S520; 88-3; YST1,,,,,,,7,6,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: 90-8, S462, S520, ST88-14, STS26T, YST1) | PMID:20049725 (cell_line: 88-3, 90-8, S462, S520, ST88-14, STS26T, YST1) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, ST88-14, STS26T) | PMID:23685747 (cell_line: S462, ST88-14, STS26T) | PMID:24681606 (cell_line: S462, ST88-14, STS26T) | PMID:24824755 (cell_line: 90-8, ST88-14) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: 90-8, S462, ST88-14, STS26T) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: ST88-14, STS26T) | PMID:33658640 (cell_line: S462, ST88-14) | PMID:35511749 (cell_line: S462, STS26T) | PMID:36322658 (cell_line: STS26T) | PMID:37164978 (cell_line: S462, STS26T) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462, ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14, STS26T) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,2013,Nature genetics,,,S462TY; ST88-14; S462; T265; STS26T; iHSCs; K562,,,,,,,7,4,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: S462, ST88-14, STS26T) | PMID:20049725 (cell_line: S462, ST88-14, STS26T) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:23685747 (cell_line: K562, S462, S462TY, ST88-14, STS26T, T265, iHSCs) | PMID:24681606 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:24824755 (cell_line: ST88-14) | PMID:30055648 (cell_line: S462, T265) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, ST88-14, STS26T) | PMID:32948135 (cell_line: S462, T265) | PMID:33032988 (cell_line: ST88-14, STS26T) | PMID:33658640 (cell_line: S462, ST88-14) | PMID:35511749 (cell_line: S462, STS26T) | PMID:36322658 (cell_line: STS26T, T265) | PMID:37164978 (cell_line: S462, S462TY, STS26T, T265) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462, ST88-14) | PMID:38201517 (cell_line: S462TY, ST88-14) | PMID:38203448 (cell_line: S462TY, ST88-14, STS26T, T265) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:40025578 (cell_line: K562) | PMID:41001593 (cell_line: S462, T265) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: S462TY, ST88-14, iHSCs)"
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,2020,The Journal of biological chemistry,,,DH10Bac cells; BL21(DE3); Sf9 cells; Tni-FNL cells; NF1-null HEK293T cell line; HEK293T cells,NF1 isoform 2,,,,,,7,2,High,"PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: BL21(DE3), DH10Bac cells, HEK293T cells, NF1-null HEK293T cell line, Sf9 cells, Tni-FNL cells; genetic_reagent: NF1 isoform 2) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:36689660 (genetic_reagent: NF1 isoform 2) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)"
PMID:32457840,10.3389/fonc.2020.00687,"TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.",2020,Frontiers in oncology,,Merlin,MiaPaCa-2; PANC1; BxPc3; AsPC-1; HPDE H6c7,Merlin,,,,,,7,2,High,"PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin) | PMID:24595234 (antibody: Merlin) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin) | PMID:30274821 (antibody: Merlin) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin; cell_line: AsPC-1, BxPc3, HPDE H6c7, MiaPaCa-2, PANC1; genetic_reagent: Merlin) | PMID:33934112 (cell_line: BxPc3, MiaPaCa-2, PANC1) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (antibody: Merlin)"
PMID:32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,2020,Neuro-oncology advances,,,ST88-14; 90-8; S462; SNF96.2; STS26T; HS-Sch-2; CCD-1112Sk,,,,,,,7,4,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: 90-8, S462, ST88-14, STS26T) | PMID:20049725 (cell_line: 90-8, S462, ST88-14, STS26T) | PMID:23175151 (cell_line: SNF96.2) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, ST88-14, STS26T) | PMID:23685747 (cell_line: S462, ST88-14, STS26T) | PMID:24681606 (cell_line: S462, ST88-14, STS26T) | PMID:24824755 (cell_line: 90-8, ST88-14) | PMID:29438698 (cell_line: SNF96.2) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: 90-8, CCD-1112Sk, HS-Sch-2, S462, SNF96.2, ST88-14, STS26T) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: ST88-14, STS26T) | PMID:33658640 (cell_line: S462, ST88-14) | PMID:35511749 (cell_line: HS-Sch-2, S462, SNF96.2, STS26T) | PMID:36322658 (cell_line: SNF96.2, STS26T) | PMID:37164978 (cell_line: S462, STS26T) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462, ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14, STS26T) | PMID:38216572 (cell_line: SNF96.2, ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: SNF96.2, ST88-14) | PMID:40025578 (cell_line: SNF96.2) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,2022,Nature communications,Nf1 c.5425 C > T ; Arg1809Cys; R681X Nf1; Nf1 flox/flox ; Hoxb7-Cre; Nf1 f/neo ; hGFAP-Cre,,BJFF.6; Normal human Schwann cells (Sciencell),shNF1,,,,,,7,5,High,"PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: Nf1 flox/flox, hGFAP-Cre) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:35589737 (animal_model: Arg1809Cys, Hoxb7-Cre, Nf1 c.5425 C > T, Nf1 f/neo, R681X Nf1; cell_line: BJFF.6, Normal human Schwann cells (Sciencell); genetic_reagent: shNF1) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,2023,Brain : a journal of neurology,Periostin-CRE;NF2 fl/fl; Periostin-CRE;NF2 fl/fl YAP fl/fl; Periostin-CRE;NF2 fl/fl TAZ fl/fl; P0-CRE,,Ben-Men-1; KT21-MG1; 293FT,,,,,,,7,6,High,"PMID:17924978 (animal_model: NF2 fl/fl) | PMID:24817309 (animal_model: NF2 fl/fl) | PMID:26219339 (cell_line: Ben-Men-1) | PMID:28126595 (cell_line: Ben-Men-1) | PMID:33273014 (cell_line: Ben-Men-1) | PMID:36148553 (animal_model: NF2 fl/fl TAZ fl/fl, NF2 fl/fl YAP fl/fl, P0-CRE, Periostin-CRE, Periostin-CRE, Periostin-CRE; cell_line: 293FT, Ben-Men-1, KT21-MG1) | PMID:38945076 (animal_model: NF2 fl/fl) | PMID:41444363 (animal_model: NF2 fl/fl)"
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,2022,Science advances,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,,SNF96.2; hTERT NF1 ipn02.3 2λ; ipn95.11bC; MPNST642; T265; STS26T,,,,,,,7,6,High,"PMID:18483311 (cell_line: STS26T) | PMID:20049725 (cell_line: STS26T) | PMID:23175151 (cell_line: SNF96.2) | PMID:23535903 (cell_line: STS26T, T265) | PMID:23685747 (cell_line: STS26T, T265) | PMID:24681606 (cell_line: STS26T, T265) | PMID:29438698 (cell_line: SNF96.2) | PMID:30055648 (cell_line: T265) | PMID:32642733 (cell_line: SNF96.2, STS26T) | PMID:32948135 (cell_line: T265) | PMID:33032988 (cell_line: STS26T) | PMID:35511749 (cell_line: SNF96.2, STS26T) | PMID:36322658 (animal_model: Dhh-Cre, NF1 fl/fl Tp53 fl/fl Eed fl/fl; cell_line: MPNST642, SNF96.2, STS26T, T265, hTERT NF1 ipn02.3 2λ, ipn95.11bC) | PMID:37164978 (cell_line: STS26T, T265) | PMID:37410426 (cell_line: STS26T) | PMID:38203448 (cell_line: STS26T, T265) | PMID:38216572 (cell_line: SNF96.2) | PMID:39269317 (cell_line: SNF96.2) | PMID:40025578 (cell_line: SNF96.2) | PMID:41001593 (cell_line: T265)"
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,2023,PloS one,NPcis,,TM-31; LN319; 17; 5653; 5746,,,spheroid culture system,,,,7,6,High,"PMID:36730269 (advanced_cellular_model: spheroid culture system; animal_model: NPcis; cell_line: 17, 5653, 5746, LN319, TM-31)"
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,2023,Cancers,,,ipNF95.6; ipnNF95.11c; ipNF06.2A; ipNF05.5-MX; ipNF95.11b C/T; ipNF02.3 2λ; ipNF02.8,,,,,,,7,5,High,"PMID:33442015 (cell_line: ipNF95.6) | PMID:33934112 (cell_line: ipNF95.6) | PMID:35741605 (cell_line: ipNF95.6, ipnNF95.11c) | PMID:37164978 (cell_line: ipNF06.2A) | PMID:38136356 (cell_line: ipNF02.3 2λ, ipNF02.8, ipNF05.5-MX, ipNF06.2A, ipNF95.11b C/T, ipNF95.6, ipnNF95.11c) | PMID:39129390 (cell_line: ipnNF95.11c) | PMID:40723243 (cell_line: ipnNF95.11c)"
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,2024,PloS one,,,,,,,,Cirrus HD-OCT; Teller acuity cards; Cardiff acuity cards; Lea cards; KM (Konstantin Moutakis) cards; Humphrey Field Analyzer perimetry; World Health Organization Categories of Childhood VI scale,,7,1,High,"PMID:38990917 (clinical_assessment_tool: Cardiff acuity cards, Cirrus HD-OCT, Humphrey Field Analyzer perimetry, KM (Konstantin Moutakis) cards, Lea cards, Teller acuity cards, World Health Organization Categories of Childhood VI scale)"
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,2014,eLife,Nf1 flox/flox; hGFAP-cre; Math1-cre; L7-cre; Nestin-creER,NF1,,,,,,,,6,6,High,"PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: L7-cre, Math1-cre, Nestin-creER, Nf1 flox/flox, hGFAP-cre; antibody: NF1) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28166733 (antibody: NF1) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:30479396 (antibody: NF1) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:38714355 (antibody: NF1) | PMID:39129390 (antibody: NF1) | PMID:39472976 (antibody: NF1) | PMID:40684195 (animal_model: Nf1 flox/flox) | PMID:41022755 (antibody: NF1) | PMID:41564118 (antibody: NF1)"
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,2015,Oncotarget,,NF2,Ben-Men-1; 293T cells; AC007-hTERT; AC028,NF2,,,,,,6,4,High,"PMID:24595234 (genetic_reagent: NF2) | PMID:25026211 (cell_line: 293T cells) | PMID:26219339 (antibody: NF2; cell_line: 293T cells, AC007-hTERT, AC028, Ben-Men-1; genetic_reagent: NF2) | PMID:28126595 (cell_line: Ben-Men-1) | PMID:29715273 (antibody: NF2; genetic_reagent: NF2) | PMID:30274821 (genetic_reagent: NF2) | PMID:33273014 (cell_line: Ben-Men-1; genetic_reagent: NF2) | PMID:36148553 (cell_line: Ben-Men-1) | PMID:40025578 (cell_line: 293T cells)"
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,2018,EBioMedicine,,Merlin,HEI-193; Human Schwann cells (HSCs); RT4-D6P2T schwannoma cells,NF2; NF2 shRNA,,,,,,6,5,High,"PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin) | PMID:21111000 (cell_line: HEI-193) | PMID:24595234 (antibody: Merlin; genetic_reagent: NF2) | PMID:26219339 (genetic_reagent: NF2) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin; genetic_reagent: NF2) | PMID:30274821 (antibody: Merlin; cell_line: HEI-193, Human Schwann cells (HSCs), RT4-D6P2T schwannoma cells; genetic_reagent: NF2, NF2 shRNA) | PMID:30617350 (cell_line: HEI-193) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:33273014 (genetic_reagent: NF2) | PMID:38216587 (cell_line: HEI-193) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (antibody: Merlin)"
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,2021,Cell death & disease,,,HEK293T cells; ipNF95.6; MiaPaCa-2; PANC1; BxPc3; U251,,,,,,,6,1,High,"PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:25043298 (cell_line: U251) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:32419643 (cell_line: U251) | PMID:32457840 (cell_line: BxPc3, MiaPaCa-2, PANC1) | PMID:33442015 (cell_line: ipNF95.6) | PMID:33934112 (cell_line: BxPc3, HEK293T cells, MiaPaCa-2, PANC1, U251, ipNF95.6) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35741605 (cell_line: ipNF95.6) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38136356 (cell_line: ipNF95.6) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)"
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,2023,Nature communications,,,S462TY; S462; T265; STS26T; HSC1λ; ipNF06.2A,,,,,,,6,4,High,"PMID:18483311 (cell_line: S462, STS26T) | PMID:20049725 (cell_line: S462, STS26T) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, S462TY, STS26T, T265) | PMID:23685747 (cell_line: S462, S462TY, STS26T, T265) | PMID:24681606 (cell_line: S462, S462TY, STS26T, T265) | PMID:30055648 (cell_line: S462, T265) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, STS26T) | PMID:32948135 (cell_line: S462, T265) | PMID:33032988 (cell_line: STS26T) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: S462, STS26T) | PMID:36322658 (cell_line: STS26T, T265) | PMID:37164978 (cell_line: HSC1λ, S462, S462TY, STS26T, T265, ipNF06.2A) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462) | PMID:38136356 (cell_line: ipNF06.2A) | PMID:38201517 (cell_line: S462TY) | PMID:38203448 (cell_line: S462TY, STS26T, T265) | PMID:38502231 (cell_line: S462) | PMID:41001593 (cell_line: S462, T265) | PMID:41022755 (cell_line: S462) | PMID:41036607 (cell_line: S462TY)"
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,2024,Molecular metabolism,Nf1-IF; Nf1-PS; Nf1-IFPS,neurofibromin,MCF7,NF1 gRNA,,,,,,6,5,High,"PMID:29438698 (antibody: neurofibromin) | PMID:29847659 (antibody: neurofibromin) | PMID:36241865 (antibody: neurofibromin) | PMID:37446790 (antibody: neurofibromin) | PMID:38216123 (animal_model: Nf1-IF, Nf1-IFPS, Nf1-PS; antibody: neurofibromin; cell_line: MCF7; genetic_reagent: NF1 gRNA) | PMID:38481529 (antibody: neurofibromin) | PMID:39890807 (antibody: neurofibromin) | PMID:40507334 (cell_line: MCF7)"
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,2024,Frontiers in cell and developmental biology,,neurofibromin,NF1-1 hiPSC line; NF1-2 hiPSC line; WT-1 hiPSC line; WT-2 hiPSC line,Nf1,,,,,,6,4,High,"PMID:29438698 (antibody: neurofibromin) | PMID:29670214 (genetic_reagent: Nf1) | PMID:29847659 (antibody: neurofibromin) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:38216123 (antibody: neurofibromin) | PMID:38481529 (antibody: neurofibromin; cell_line: NF1-1 hiPSC line, NF1-2 hiPSC line, WT-1 hiPSC line, WT-2 hiPSC line; genetic_reagent: Nf1) | PMID:39890807 (antibody: neurofibromin; genetic_reagent: Nf1)"
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,2026,Molecular cancer therapeutics,"Dhh::Cre, Nf1fl/fl, Pten",neurofibromin 1,S462TY; ST88-14; iHSCs,,,,Patient-derived xenograft (PDX) MPNST model,,,6,5,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:20049725 (cell_line: ST88-14) | PMID:23535903 (cell_line: S462TY, ST88-14) | PMID:23685747 (cell_line: S462TY, ST88-14, iHSCs) | PMID:24681606 (cell_line: S462TY, ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:32642733 (cell_line: ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33658640 (cell_line: ST88-14) | PMID:37164978 (cell_line: S462TY) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: S462TY, ST88-14) | PMID:38203448 (cell_line: S462TY, ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (animal_model: Dhh::Cre, Nf1fl/fl, Pten; antibody: neurofibromin 1; cell_line: S462TY, ST88-14, iHSCs; patient_derived_model: Patient-derived xenograft (PDX) MPNST model)"
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",2013,Cancer discovery,,,S462TY; ST88-14; S462; T265; STS26T,,,,,,,5,4,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: S462, ST88-14, STS26T) | PMID:20049725 (cell_line: S462, ST88-14, STS26T) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:23685747 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:24681606 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:24824755 (cell_line: ST88-14) | PMID:30055648 (cell_line: S462, T265) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, ST88-14, STS26T) | PMID:32948135 (cell_line: S462, T265) | PMID:33032988 (cell_line: ST88-14, STS26T) | PMID:33658640 (cell_line: S462, ST88-14) | PMID:35511749 (cell_line: S462, STS26T) | PMID:36322658 (cell_line: STS26T, T265) | PMID:37164978 (cell_line: S462, S462TY, STS26T, T265) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462, ST88-14) | PMID:38201517 (cell_line: S462TY, ST88-14) | PMID:38203448 (cell_line: S462TY, ST88-14, STS26T, T265) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41001593 (cell_line: S462, T265) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: S462TY, ST88-14)"
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,2014,Oncogene,,,Normal human Schwann cells (NHSC); MPNST cell lines; MPNST 88-14 cells; MPNST S462-TY cells,NF1-GRD,,,,,,5,4,High,"PMID:16835260 (genetic_reagent: NF1-GRD) | PMID:18413802 (cell_line: MPNST cell lines) | PMID:24509877 (cell_line: MPNST 88-14 cells, MPNST S462-TY cells, MPNST cell lines, Normal human Schwann cells (NHSC); genetic_reagent: NF1-GRD) | PMID:35393510 (genetic_reagent: NF1-GRD) | PMID:38000020 (genetic_reagent: NF1-GRD)"
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,2014,Oncotarget,,,S462TY; ST88-14; S462; T265; STS26T,,,,,,,5,4,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: S462, ST88-14, STS26T) | PMID:20049725 (cell_line: S462, ST88-14, STS26T) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:23685747 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:24681606 (cell_line: S462, S462TY, ST88-14, STS26T, T265) | PMID:24824755 (cell_line: ST88-14) | PMID:30055648 (cell_line: S462, T265) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, ST88-14, STS26T) | PMID:32948135 (cell_line: S462, T265) | PMID:33032988 (cell_line: ST88-14, STS26T) | PMID:33658640 (cell_line: S462, ST88-14) | PMID:35511749 (cell_line: S462, STS26T) | PMID:36322658 (cell_line: STS26T, T265) | PMID:37164978 (cell_line: S462, S462TY, STS26T, T265) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: S462, STS26T) | PMID:38127282 (cell_line: S462, ST88-14) | PMID:38201517 (cell_line: S462TY, ST88-14) | PMID:38203448 (cell_line: S462TY, ST88-14, STS26T, T265) | PMID:38216572 (cell_line: ST88-14) | PMID:38502231 (cell_line: S462) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41001593 (cell_line: S462, T265) | PMID:41022755 (cell_line: S462, ST88-14) | PMID:41036607 (cell_line: S462TY, ST88-14)"
PMID:25043298,10.1038/onc.2014.185,Oncogenic role of Merlin/NF2 in glioblastoma.,2015,Oncogene,,S518-Merlin,U251,Merlin siRNA; HA-Merlin; S518A HA-Merlin,,,,,,5,4,High,"PMID:25043298 (antibody: S518-Merlin; cell_line: U251; genetic_reagent: HA-Merlin, Merlin siRNA, S518A HA-Merlin) | PMID:32419643 (cell_line: U251) | PMID:33934112 (cell_line: U251)"
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,2018,Orphanet journal of rare diseases,,,NF37; NF87; CT10; CT11; CT12,,,,,,,5,2,High,"PMID:29941005 (cell_line: CT10, CT11, CT12, NF37, NF87)"
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,2021,The Journal of biological chemistry,,NF2/merlin,Ben-Men-1; AC-CRISPR; MN1-LF,NF2,,,,,,5,5,High,"PMID:19144871 (antibody: NF2/merlin) | PMID:24595234 (genetic_reagent: NF2) | PMID:26219339 (cell_line: Ben-Men-1; genetic_reagent: NF2) | PMID:28126595 (cell_line: Ben-Men-1) | PMID:29715273 (genetic_reagent: NF2) | PMID:30274821 (genetic_reagent: NF2) | PMID:33273014 (antibody: NF2/merlin; cell_line: AC-CRISPR, Ben-Men-1, MN1-LF; genetic_reagent: NF2) | PMID:36148553 (cell_line: Ben-Men-1) | PMID:38216572 (antibody: NF2/merlin)"
PMID:35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,2022,Brain sciences,,,ipNF05.5 (mixed clone); ipNF05.5 (single clone); ipNF95.11bC; ipNF95.6; ipnNF95.11c,,,,,,,5,5,High,"PMID:33442015 (cell_line: ipNF95.6) | PMID:33934112 (cell_line: ipNF95.6) | PMID:35741605 (cell_line: ipNF05.5 (mixed clone), ipNF05.5 (single clone), ipNF95.11bC, ipNF95.6, ipnNF95.11c) | PMID:36689660 (cell_line: ipNF95.11bC) | PMID:38136356 (cell_line: ipNF95.6, ipnNF95.11c) | PMID:39061138 (cell_line: ipNF95.11bC) | PMID:39129390 (cell_line: ipNF95.11bC, ipnNF95.11c) | PMID:40723243 (cell_line: ipNF05.5 (single clone), ipNF95.11bC, ipnNF95.11c) | PMID:40862755 (cell_line: ipNF95.11bC)"
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,2022,Cancer discovery,,,HEK293T cells; M1; M3; M4; M6,,,,,,,5,4,High,"PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells, M1, M3, M4, M6) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells, M1, M3, M4, M6) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)"
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,2023,The Journal of clinical investigation,H7;Nf1mut,,hTERT ipNF05.5; hTERT ipn02.3 2λ; E13.5 DRG neurosphere cells,Nf1,,,,,,5,4,High,"PMID:29670214 (genetic_reagent: Nf1) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (genetic_reagent: Nf1) | PMID:37140985 (animal_model: H7, Nf1mut; cell_line: E13.5 DRG neurosphere cells, hTERT ipNF05.5, hTERT ipn02.3 2λ; genetic_reagent: Nf1) | PMID:37446790 (genetic_reagent: Nf1) | PMID:38127282 (cell_line: hTERT ipn02.3 2λ) | PMID:38481529 (genetic_reagent: Nf1) | PMID:39890807 (genetic_reagent: Nf1)"
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,2023,Cancers,,,S462TY; iSC; A549; ST88-14; MCF10A,,,,,,,5,2,High,"PMID:18367665 (cell_line: ST88-14, iSC) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:20049725 (cell_line: ST88-14) | PMID:23535903 (cell_line: S462TY, ST88-14) | PMID:23685747 (cell_line: S462TY, ST88-14) | PMID:24681606 (cell_line: S462TY, ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:32642733 (cell_line: ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33658640 (cell_line: ST88-14) | PMID:37164978 (cell_line: S462TY) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: A549, MCF10A, S462TY, ST88-14, iSC) | PMID:38203448 (cell_line: S462TY, ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: S462TY, ST88-14)"
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,2023,International journal of molecular sciences,,,S462TY; ST88-14; T265; STS26T; Normal human Schwann cells (HSC),,,,,,,5,3,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14, STS26T) | PMID:20049725 (cell_line: ST88-14, STS26T) | PMID:23535903 (cell_line: S462TY, ST88-14, STS26T, T265) | PMID:23685747 (cell_line: S462TY, ST88-14, STS26T, T265) | PMID:24681606 (cell_line: S462TY, ST88-14, STS26T, T265) | PMID:24824755 (cell_line: ST88-14) | PMID:30055648 (cell_line: T265) | PMID:32642733 (cell_line: ST88-14, STS26T) | PMID:32948135 (cell_line: T265) | PMID:33032988 (cell_line: ST88-14, STS26T) | PMID:33658640 (cell_line: ST88-14) | PMID:35511749 (cell_line: STS26T) | PMID:36322658 (cell_line: STS26T, T265) | PMID:37164978 (cell_line: S462TY, STS26T, T265) | PMID:37246765 (cell_line: ST88-14) | PMID:37410426 (cell_line: STS26T) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: S462TY, ST88-14) | PMID:38203448 (cell_line: Normal human Schwann cells (HSC), S462TY, ST88-14, STS26T, T265) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41001593 (cell_line: T265) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: S462TY, ST88-14)"
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,2024,The Journal of clinical investigation,cisNP,,H358 cells; S462; cis MPNST cell line; HTS-Luc MPNST cell line,,,,,,,5,4,High,"PMID:18483311 (cell_line: S462) | PMID:20049725 (cell_line: S462) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462) | PMID:23685747 (cell_line: S462) | PMID:24681606 (cell_line: S462) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462) | PMID:32948135 (cell_line: S462) | PMID:33658640 (cell_line: S462) | PMID:34010628 (animal_model: cisNP) | PMID:35393510 (cell_line: cis MPNST cell line) | PMID:35511749 (cell_line: S462) | PMID:37164978 (cell_line: S462) | PMID:37410426 (cell_line: S462) | PMID:38127282 (cell_line: S462) | PMID:38502231 (animal_model: cisNP; cell_line: H358 cells, HTS-Luc MPNST cell line, S462, cis MPNST cell line) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462)"
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,2025,Acta neuropathologica communications,,,SNF96.2; K562; 293T cells; HFFs; NCI-H266,,,,,,,5,1,High,"PMID:23175151 (cell_line: SNF96.2) | PMID:23685747 (cell_line: K562) | PMID:25026211 (cell_line: 293T cells) | PMID:26219339 (cell_line: 293T cells) | PMID:29438698 (cell_line: SNF96.2) | PMID:32642733 (cell_line: SNF96.2) | PMID:35511749 (cell_line: SNF96.2) | PMID:36322658 (cell_line: SNF96.2) | PMID:38216572 (cell_line: SNF96.2) | PMID:39269317 (cell_line: SNF96.2) | PMID:40025578 (cell_line: 293T cells, HFFs, K562, NCI-H266, SNF96.2)"
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,2025,The Journal of clinical investigation,,neurofibromin/NF1,HEK293T cells; HeLa cells; LUVA cells,human neurofibromin,,,,,Nf1+/-,5,3,High,"PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:32383545 (cell_line: HeLa cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:36420221 (cell_line: HeLa cells) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (antibody: neurofibromin/NF1; cell_line: HEK293T cells, HeLa cells, LUVA cells; genetic_reagent: human neurofibromin)"
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,2025,Cancers,DhhCre;Nf1f/f;Luciferase,,ipNF05.5 (single clone); ipNF95.11bC; ipnNF95.11c; ipNF05.5 Mixed Clones,,,,,,,5,5,High,"PMID:34010628 (animal_model: Nf1f/f) | PMID:35741605 (cell_line: ipNF05.5 (single clone), ipNF95.11bC, ipnNF95.11c) | PMID:36322658 (animal_model: DhhCre) | PMID:36689660 (cell_line: ipNF95.11bC) | PMID:38136356 (cell_line: ipnNF95.11c) | PMID:39061138 (cell_line: ipNF95.11bC) | PMID:39129390 (cell_line: ipNF95.11bC, ipnNF95.11c) | PMID:40723243 (animal_model: Luciferase; cell_line: ipNF05.5 (single clone), ipNF05.5 Mixed Clones, ipNF95.11bC, ipnNF95.11c) | PMID:40862755 (cell_line: ipNF95.11bC)"
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,2025,Molecular & cellular oncology,,,S462; T265; NSF1; BRGN; primary human Schwann cells (HSC),,,,,,,5,3,High,"PMID:18483311 (cell_line: S462) | PMID:20049725 (cell_line: S462) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, T265) | PMID:23685747 (cell_line: S462, T265) | PMID:24681606 (cell_line: S462, T265) | PMID:30055648 (cell_line: S462, T265) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462) | PMID:32948135 (cell_line: NSF1, S462, T265) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: S462) | PMID:36322658 (cell_line: T265) | PMID:37164978 (cell_line: S462, T265) | PMID:37410426 (cell_line: S462) | PMID:38127282 (cell_line: S462) | PMID:38203448 (cell_line: T265) | PMID:38502231 (cell_line: S462) | PMID:41001593 (cell_line: BRGN, NSF1, S462, T265, primary human Schwann cells (HSC)) | PMID:41022755 (cell_line: S462)"
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,2008,The Journal of pharmacology and experimental therapeutics,,,iSC; ST88-14; NF90-8; Primary normal rat Schwann cells,,,,,,,4,2,High,"PMID:18367665 (cell_line: NF90-8, Primary normal rat Schwann cells, ST88-14, iSC) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:20049725 (cell_line: ST88-14) | PMID:23535903 (cell_line: ST88-14) | PMID:23685747 (cell_line: ST88-14) | PMID:24681606 (cell_line: ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:32642733 (cell_line: ST88-14) | PMID:33032988 (cell_line: NF90-8, ST88-14) | PMID:33658640 (cell_line: NF90-8, ST88-14) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: ST88-14, iSC) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,2008,Molecular cancer therapeutics,,,ST88-14; MPNST cell lines; LS141; DDLS,,,,,,,4,2,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: DDLS, LS141, MPNST cell lines, ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:20049725 (cell_line: ST88-14) | PMID:23535903 (cell_line: ST88-14) | PMID:23685747 (cell_line: ST88-14) | PMID:24509877 (cell_line: MPNST cell lines) | PMID:24681606 (cell_line: ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:32642733 (cell_line: ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33658640 (cell_line: ST88-14) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,2010,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,Nf1(ob) (-/-); 2.3-kb α1(I) collagen-cre Nf1 flox/flox; Nf1 flox/flox,,Nf1 flox/flox calvaria osteoblasts,,,,,,,4,4,High,"PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: 2.3-kb α1(I) collagen-cre Nf1 flox/flox, Nf1 flox/flox, Nf1(ob) (-/-); cell_line: Nf1 flox/flox calvaria osteoblasts) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,2012,Cell,Nf1 hGFAP CKO; Nf1 NcreER CKO,,,Nf1 flox; Nf1 KO,,,,,,4,4,High,"PMID:22901811 (animal_model: Nf1 NcreER CKO, Nf1 hGFAP CKO; genetic_reagent: Nf1 KO, Nf1 flox)"
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,2014,PloS one,y w Mer4; 4/FM7; T80-Gal4 y w Mer4,Merlin,,NF2,,,,,,4,4,High,"PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin) | PMID:24595234 (animal_model: 4/FM7, T80-Gal4 y w Mer4, y w Mer4; antibody: Merlin; genetic_reagent: NF2) | PMID:26219339 (genetic_reagent: NF2) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin; genetic_reagent: NF2) | PMID:30274821 (antibody: Merlin; genetic_reagent: NF2) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:33273014 (genetic_reagent: NF2) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (antibody: Merlin)"
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,2015,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,"TetOff-Osx-/-Nf1; Osx-/-Nf1flox/flox; Osx-tTA,tetO-cre;Nf1flox/flox",,Nf1flox/flox bone marrow stromal cells,,,,,,,4,4,High,"PMID:19191334 (animal_model: Nf1flox/flox) | PMID:20200958 (animal_model: Nf1flox/flox) | PMID:21439418 (animal_model: Nf1flox/flox) | PMID:25043591 (animal_model: Osx-/-Nf1flox/flox, Osx-tTA,tetO-cre, TetOff-Osx-/-Nf1; cell_line: Nf1flox/flox bone marrow stromal cells) | PMID:25535838 (animal_model: Nf1flox/flox) | PMID:25772366 (animal_model: Nf1flox/flox) | PMID:28525381 (animal_model: Nf1flox/flox) | PMID:29787563 (animal_model: Nf1flox/flox) | PMID:29847659 (animal_model: Nf1flox/flox) | PMID:34935315 (animal_model: Nf1flox/flox) | PMID:36890585 (animal_model: Nf1flox/flox) | PMID:40684195 (animal_model: Nf1flox/flox)"
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,2017,EBioMedicine,,Merlin; phospho-Merlin,Ben-Men-1; Human meningeal cells (HMC),,,,,,,4,3,High,"PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin) | PMID:24595234 (antibody: Merlin) | PMID:26219339 (cell_line: Ben-Men-1) | PMID:28126595 (antibody: Merlin, phospho-Merlin; cell_line: Ben-Men-1, Human meningeal cells (HMC)) | PMID:29715273 (antibody: Merlin) | PMID:30274821 (antibody: Merlin) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:33273014 (cell_line: Ben-Men-1) | PMID:36148553 (cell_line: Ben-Men-1) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (antibody: Merlin)"
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,2017,BMC genomics,,NF1; SUZ12,HEK293T cells; U87-MG,,,,,,,4,3,High,"PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1, SUZ12; cell_line: HEK293T cells, U87-MG) | PMID:29402968 (cell_line: HEK293T cells) | PMID:30479396 (antibody: NF1) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38216587 (cell_line: HEK293T cells) | PMID:38714355 (antibody: NF1) | PMID:39129390 (antibody: NF1) | PMID:39269317 (cell_line: HEK293T cells) | PMID:39472976 (antibody: NF1) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells) | PMID:41022755 (antibody: NF1) | PMID:41564118 (antibody: NF1)"
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,2020,BMC cancer,,,S462; T265; NSF1; B8 fibroblasts,,,,,,,4,3,High,"PMID:18483311 (cell_line: S462) | PMID:20049725 (cell_line: S462) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, T265) | PMID:23685747 (cell_line: S462, T265) | PMID:24681606 (cell_line: S462, T265) | PMID:30055648 (cell_line: S462, T265) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462) | PMID:32948135 (cell_line: B8 fibroblasts, NSF1, S462, T265) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: S462) | PMID:36322658 (cell_line: T265) | PMID:37164978 (cell_line: S462, T265) | PMID:37410426 (cell_line: S462) | PMID:38127282 (cell_line: S462) | PMID:38203448 (cell_line: T265) | PMID:38502231 (cell_line: S462) | PMID:41001593 (cell_line: NSF1, S462, T265) | PMID:41022755 (cell_line: S462)"
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,2023,Molecular therapy. Nucleic acids,NF1 R1947/+,,Schwann cells,NF1-targeting TALEN; NF1 DLR,,,,,,4,4,High,"PMID:37520682 (animal_model: NF1 R1947/+; cell_line: Schwann cells; genetic_reagent: NF1 DLR, NF1-targeting TALEN)"
PMID:38216587,10.1038/s41467-023-40408-5,Epigenetic reprogramming shapes the cellular landscape of schwannoma.,2024,Nature communications,,,"HEK293T cells; HEI-193; Human Schwann Cells (HSC, ScienCell Research Laboratories #1700); Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)",,,,,,,4,1,High,"PMID:20554030 (cell_line: HEK293T cells) | PMID:21111000 (cell_line: HEI-193) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:30274821 (cell_line: HEI-193) | PMID:30617350 (cell_line: HEI-193) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38216587 (cell_line: HEI-193, HEK293T cells, Human Schwann Cells (HSC, ScienCell Research Laboratories #1700), Mouse Schwann Cells (MSC, ScienCell Research Laboratories #M1700-57)) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)"
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,2024,Cancers,,,"ipNF95.11bC; ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71); ipNF95.11b C-RFP",,,3D rBM overlay model,,,,4,3,High,"PMID:33658640 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)) | PMID:35741605 (cell_line: ipNF95.11bC) | PMID:36689660 (cell_line: ipNF95.11bC) | PMID:39061138 (advanced_cellular_model: 3D rBM overlay model; cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11b C-RFP, ipNF95.11bC) | PMID:39129390 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC) | PMID:40723243 (cell_line: ipNF95.11bC) | PMID:40862755 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC)"
PMID:39472976,10.1186/s40478-024-01875-z,NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes.,2024,Acta neuropathologica communications,,NF1,JHH-520 cell line; GBM1 cell line; JHH-0879 cell line,,,,,,,4,1,High,"PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:30479396 (antibody: NF1) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:38714355 (antibody: NF1; cell_line: JHH-520 cell line) | PMID:39129390 (antibody: NF1) | PMID:39472976 (antibody: NF1; cell_line: GBM1 cell line, JHH-0879 cell line, JHH-520 cell line) | PMID:41022755 (antibody: NF1) | PMID:41564118 (antibody: NF1)"
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,2009,Glia,Nf1 flox/flox; Nf1+/− GFAP CKO,NF1GRP-D,,,,,,,,3,3,High,"PMID:19191334 (animal_model: Nf1 flox/flox, Nf1+/− GFAP CKO; antibody: NF1GRP-D) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:21963652 (animal_model: Nf1+/− GFAP CKO) | PMID:23225063 (animal_model: Nf1+/− GFAP CKO) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox, Nf1+/− GFAP CKO) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,2010,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",,Merlin,"Human Schwann cells (HSC; ScienCell, Carlsbad, CA)",neurofibromin 2,,,,,,3,2,High,"PMID:20195187 (antibody: Merlin; cell_line: Human Schwann cells (HSC; ScienCell, Carlsbad, CA); genetic_reagent: neurofibromin 2) | PMID:21072183 (antibody: Merlin) | PMID:24595234 (antibody: Merlin) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin) | PMID:30274821 (antibody: Merlin) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (antibody: Merlin)"
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,2010,Cancer research,Nf1 flox/flox; GFAP-Cre; Nf1flox/mut;GFAP-Cre,,Daoy,,,,,,,3,2,High,"PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:20551058 (cell_line: Daoy) | PMID:20554030 (animal_model: Nf1flox/mut) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: GFAP-Cre, GFAP-Cre, Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,2010,Journal of neuroimmunology,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",,HEK293T cells; LN428 human glioblastoma multiforme (GBM) cell line,,,,,,,3,1,High,"PMID:20554030 (animal_model: GFAP-Cre, Nf1+/− GFAP CKO, Nf1 flox/mut; cell_line: HEK293T cells, LN428 human glioblastoma multiforme (GBM) cell line) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)"
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,2010,PloS one,,Merlin,NIH-3T3; φNX packaging cell line,,,,,,,3,1,High,"PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin; cell_line: NIH-3T3, φNX packaging cell line) | PMID:24595234 (antibody: Merlin) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin) | PMID:30274821 (antibody: Merlin) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (antibody: Merlin)"
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,2013,Oncotarget,,,S462; 2884 cell line; 2885 cell line,,,,,,,3,3,High,"PMID:18483311 (cell_line: S462) | PMID:20049725 (cell_line: S462) | PMID:23328114 (cell_line: 2884 cell line, 2885 cell line, S462) | PMID:23535903 (cell_line: S462) | PMID:23685747 (cell_line: S462) | PMID:24681606 (cell_line: S462) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462) | PMID:32948135 (cell_line: S462) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: S462) | PMID:37164978 (cell_line: S462) | PMID:37410426 (cell_line: S462) | PMID:38127282 (cell_line: S462) | PMID:38502231 (cell_line: S462) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462)"
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,2013,Journal of translational medicine,,,NF96.2; NF02.2; NF94.3,,,,,,,3,3,High,"PMID:24040940 (cell_line: NF02.2, NF94.3, NF96.2) | PMID:33032988 (cell_line: NF94.3, NF96.2)"
PMID:24824755,10.1371/journal.pone.0096733,BNIP3 regulates AT101 [(-)-gossypol] induced death in malignant peripheral nerve sheath tumor cells.,2014,PloS one,,,ST88-14; T265-2c; 90-8,,,,,,,3,3,High,"PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: 90-8, ST88-14) | PMID:20049725 (cell_line: 90-8, ST88-14) | PMID:23535903 (cell_line: ST88-14) | PMID:23685747 (cell_line: ST88-14) | PMID:24681606 (cell_line: ST88-14) | PMID:24824755 (cell_line: 90-8, ST88-14, T265-2c) | PMID:32642733 (cell_line: 90-8, ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33658640 (cell_line: ST88-14) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: ST88-14)"
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,2014,Journal of molecular biology,,,Rosetta2(DE3) competent cells,Merlin isoform 1; Merlin(S518D) and Merlin(S518E) mutants,,,,,,3,2,High,"PMID:24882693 (cell_line: Rosetta2(DE3) competent cells; genetic_reagent: Merlin isoform 1, Merlin(S518D) and Merlin(S518E) mutants)"
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,2014,Cancer cell,,,293T cells; Meso-33; FC-1801,,,,,,,3,2,High,"PMID:25026211 (cell_line: 293T cells, FC-1801, Meso-33) | PMID:26219339 (cell_line: 293T cells) | PMID:40025578 (cell_line: 293T cells)"
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,2018,Cancer cell,,neurofibromin,SNF96.2; SNF02.2,,,,,,,3,3,High,"PMID:23175151 (cell_line: SNF96.2) | PMID:29438698 (antibody: neurofibromin; cell_line: SNF02.2, SNF96.2) | PMID:29847659 (antibody: neurofibromin) | PMID:32642733 (cell_line: SNF96.2) | PMID:35511749 (cell_line: SNF96.2) | PMID:36241865 (antibody: neurofibromin) | PMID:36322658 (cell_line: SNF96.2) | PMID:37446790 (antibody: neurofibromin) | PMID:38216123 (antibody: neurofibromin) | PMID:38216572 (cell_line: SNF02.2, SNF96.2) | PMID:38481529 (antibody: neurofibromin) | PMID:39269317 (cell_line: SNF96.2) | PMID:39890807 (antibody: neurofibromin) | PMID:40025578 (cell_line: SNF96.2)"
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,2019,Orphanet journal of rare diseases,,,,,,,,BoN (Burden of NF1) questionnaire; Dermatology Life Quality Index (DLQI); SF12,,3,1,High,"PMID:31053133 (clinical_assessment_tool: BoN (Burden of NF1) questionnaire, Dermatology Life Quality Index (DLQI), SF12)"
PMID:32383545,10.15252/embr.201949117,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,2020,EMBO reports,,,S462; HeLa cells; C2C12 cells,,,,,,,3,1,High,"PMID:18483311 (cell_line: S462) | PMID:20049725 (cell_line: S462) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462) | PMID:23685747 (cell_line: S462) | PMID:24681606 (cell_line: S462) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: C2C12 cells, HeLa cells, S462) | PMID:32642733 (cell_line: S462) | PMID:32948135 (cell_line: S462) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: S462) | PMID:36420221 (cell_line: HeLa cells) | PMID:37164978 (cell_line: S462) | PMID:37410426 (cell_line: S462) | PMID:37446790 (cell_line: C2C12 cells) | PMID:38127282 (cell_line: S462) | PMID:38502231 (cell_line: S462) | PMID:40590220 (cell_line: HeLa cells) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462)"
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,2021,Cell stem cell,cisNP; Nf1f/f;Trp53f/f;Nes-TK; Nf1f/f;Trp53f/f;CGD,,,,,,,,,3,3,High,"PMID:34010628 (animal_model: CGD, Nes-TK, Nf1f/f, Nf1f/f, Trp53f/f, Trp53f/f, cisNP) | PMID:38502231 (animal_model: cisNP)"
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,2021,Cell death & disease,,NF1,Neurofibromatosis 1 fibroblasts,Nf1,,,,,,3,3,High,PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:29670214 (genetic_reagent: Nf1) | PMID:30479396 (antibody: NF1) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (antibody: NF1; cell_line: Neurofibromatosis 1 fibroblasts; genetic_reagent: Nf1) | PMID:34257279 (antibody: NF1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (genetic_reagent: Nf1) | PMID:38481529 (genetic_reagent: Nf1) | PMID:38714355 (antibody: NF1) | PMID:39129390 (antibody: NF1) | PMID:39472976 (antibody: NF1) | PMID:39890807 (genetic_reagent: Nf1) | PMID:41022755 (antibody: NF1) | PMID:41564118 (antibody: NF1)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,2021,Nature,Nf1fl/fl; OPG Nf1fl/mut (Nf1+/−),,optic glioma cells,,,,,,,3,3,High,PMID:19191334 (animal_model: Nf1fl/fl) | PMID:20200958 (animal_model: Nf1fl/fl) | PMID:21439418 (animal_model: Nf1fl/fl) | PMID:25535838 (animal_model: Nf1fl/fl) | PMID:25772366 (animal_model: Nf1fl/fl) | PMID:28525381 (animal_model: Nf1fl/fl) | PMID:29787563 (animal_model: Nf1fl/fl) | PMID:29847659 (animal_model: Nf1fl/fl) | PMID:34040258 (animal_model: OPG Nf1fl/mut (Nf1+/−); cell_line: optic glioma cells) | PMID:34935315 (animal_model: Nf1fl/fl) | PMID:36890585 (animal_model: Nf1fl/fl) | PMID:40684195 (animal_model: Nf1fl/fl)
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,2022,Experimental & molecular medicine,,neurofibromin,Neural stem cells,Nf1,,,,,,3,2,High,PMID:29438698 (antibody: neurofibromin) | PMID:29670214 (genetic_reagent: Nf1) | PMID:29847659 (antibody: neurofibromin) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (antibody: neurofibromin; cell_line: Neural stem cells; genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:38216123 (antibody: neurofibromin) | PMID:38481529 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:39890807 (antibody: neurofibromin; genetic_reagent: Nf1)
PMID:36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,2023,Proceedings of the National Academy of Sciences of the United States of America,,,ipNF95.11bC; NF1-null 293T cells,NF1 isoform 2,,,,,,3,3,High,"PMID:31836666 (genetic_reagent: NF1 isoform 2) | PMID:35741605 (cell_line: ipNF95.11bC) | PMID:36689660 (cell_line: NF1-null 293T cells, ipNF95.11bC; genetic_reagent: NF1 isoform 2) | PMID:39061138 (cell_line: ipNF95.11bC) | PMID:39129390 (cell_line: ipNF95.11bC) | PMID:40723243 (cell_line: ipNF95.11bC) | PMID:40862755 (cell_line: ipNF95.11bC)"
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",2023,Clinical cancer research : an official journal of the American Association for Cancer Research,,,S462; STS26T,Cas9 and sgRNAs targeting Nf1+Cdkn2a,,,,,,3,2,High,"PMID:18483311 (cell_line: S462, STS26T) | PMID:20049725 (cell_line: S462, STS26T) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, STS26T) | PMID:23685747 (cell_line: S462, STS26T) | PMID:24681606 (cell_line: S462, STS26T) | PMID:30055648 (cell_line: S462) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462, STS26T) | PMID:32948135 (cell_line: S462) | PMID:33032988 (cell_line: STS26T) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: S462, STS26T) | PMID:36322658 (cell_line: STS26T) | PMID:37164978 (cell_line: S462, STS26T) | PMID:37410426 (cell_line: S462, STS26T; genetic_reagent: Cas9 and sgRNAs targeting Nf1+Cdkn2a) | PMID:38127282 (cell_line: S462) | PMID:38203448 (cell_line: STS26T) | PMID:38502231 (cell_line: S462) | PMID:41001593 (cell_line: S462) | PMID:41022755 (cell_line: S462)"
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,2023,"Molecules (Basel, Switzerland)",,neurofibromin,C2C12 cells,Nf1,,,,,,3,2,High,PMID:29438698 (antibody: neurofibromin) | PMID:29670214 (genetic_reagent: Nf1) | PMID:29847659 (antibody: neurofibromin) | PMID:32383545 (cell_line: C2C12 cells) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (antibody: neurofibromin; cell_line: C2C12 cells; genetic_reagent: Nf1) | PMID:38216123 (antibody: neurofibromin) | PMID:38481529 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:39890807 (antibody: neurofibromin; genetic_reagent: Nf1)
PMID:38907342,10.1186/s40478-024-01821-z,"snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response.",2024,Acta neuropathologica communications,,,icNF97.2a; icNF97.2b; icNF98.4d,,,,,,,3,3,High,"PMID:38907342 (cell_line: icNF97.2a, icNF97.2b, icNF98.4d) | PMID:41564118 (cell_line: icNF97.2a, icNF97.2b, icNF98.4d)"
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,2024,Disease models & mechanisms,Tg(U6x:nf2a/b-4sgRNA),Merlin,,nf2a/b-4sgRNA,,,,,,3,3,High,PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin) | PMID:24595234 (antibody: Merlin) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin) | PMID:30274821 (antibody: Merlin) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:38945076 (antibody: Merlin) | PMID:39415595 (animal_model: Tg(U6x:nf2a/b-4sgRNA); antibody: Merlin; genetic_reagent: nf2a/b-4sgRNA)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,2025,Scientific reports,,neurofibromin,ipn97.4 immortalized human Schwann cells,Nf1,,,,,,3,3,High,PMID:29438698 (antibody: neurofibromin) | PMID:29670214 (genetic_reagent: Nf1) | PMID:29847659 (antibody: neurofibromin) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:38216123 (antibody: neurofibromin) | PMID:38481529 (antibody: neurofibromin; genetic_reagent: Nf1) | PMID:39890807 (antibody: neurofibromin; cell_line: ipn97.4 immortalized human Schwann cells; genetic_reagent: Nf1)
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,2025,Cells,,,"ipNF95.11bC; ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)",,,TAME chips,,,,3,2,High,"PMID:33658640 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71)) | PMID:35741605 (cell_line: ipNF95.11bC) | PMID:36689660 (cell_line: ipNF95.11bC) | PMID:39061138 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC) | PMID:39129390 (cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC) | PMID:40723243 (cell_line: ipNF95.11bC) | PMID:40862755 (advanced_cellular_model: TAME chips; cell_line: ipNF05.5 (hTERT NF1 ipNF05.5, RRID: CVCL_UI71), ipNF95.11bC)"
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,2006,Human molecular genetics,,,,NF1-GRD; 1276P NF1 GRD,,,,,Nf1+/-,2,2,High,"PMID:16835260 (genetic_reagent: 1276P NF1 GRD, NF1-GRD) | PMID:24509877 (genetic_reagent: NF1-GRD) | PMID:35393510 (genetic_reagent: NF1-GRD) | PMID:38000020 (genetic_reagent: NF1-GRD)"
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,2008,"Brain pathology (Zurich, Switzerland)",Nf2flox/flox; Nf2 flox2/flox2 ;p16 Ink4a*/*,,,,,,,,,2,2,High,"PMID:17924978 (animal_model: Nf2 flox2/flox2, Nf2flox/flox, p16 Ink4a*/*) | PMID:24817309 (animal_model: Nf2 flox2/flox2, Nf2flox/flox) | PMID:38945076 (animal_model: Nf2 flox2/flox2, Nf2flox/flox) | PMID:41444363 (animal_model: Nf2 flox2/flox2, Nf2flox/flox)"
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,2008,Cancer cell,Nf1 flox; Nf1/p53-/-,,,,,,,,Nf1+/-,2,2,High,"PMID:18242513 (animal_model: Nf1 flox, Nf1/p53-/-) | PMID:21551250 (animal_model: Nf1 flox) | PMID:21681782 (animal_model: Nf1 flox) | PMID:21726432 (animal_model: Nf1 flox) | PMID:32839340 (animal_model: Nf1 flox) | PMID:33078583 (animal_model: Nf1 flox)"
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,2011,Molecular cancer therapeutics,Nf1 flox/flox; GFAP-Cre,,K4622 grade II glioma cell line,,,,,,,2,2,High,"PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21216928 (cell_line: K4622 grade II glioma cell line) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: GFAP-Cre, Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,2011,Bone,Nf1 flox/flox; Nf1(flox/-);Col2.3Cre(+),,,,,,,,Nf1+/-,2,2,High,"PMID:18242513 (animal_model: Nf1(flox/-)) | PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Col2.3Cre(+), Nf1 flox/flox) | PMID:21551250 (animal_model: Nf1(flox/-)) | PMID:21681782 (animal_model: Nf1(flox/-)) | PMID:21726432 (animal_model: Nf1(flox/-)) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:32839340 (animal_model: Nf1(flox/-)) | PMID:33078583 (animal_model: Nf1(flox/-)) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,2011,American journal of hematology,Nf1 flox; Nf1 fcr,,,,,,,,,2,2,High,"PMID:18242513 (animal_model: Nf1 flox) | PMID:21551250 (animal_model: Nf1 flox) | PMID:21681782 (animal_model: Nf1 fcr, Nf1 flox) | PMID:21726432 (animal_model: Nf1 flox) | PMID:32839340 (animal_model: Nf1 flox) | PMID:33078583 (animal_model: Nf1 flox)"
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,2011,BMC medicine,Nf1 flox; Nf1Prx1-/-,,,,,,,,,2,2,High,"PMID:18242513 (animal_model: Nf1 flox) | PMID:21551250 (animal_model: Nf1 flox) | PMID:21681782 (animal_model: Nf1 flox) | PMID:21726432 (animal_model: Nf1 flox, Nf1Prx1-/-) | PMID:24465906 (animal_model: Nf1Prx1-/-) | PMID:32839340 (animal_model: Nf1 flox) | PMID:33078583 (animal_model: Nf1 flox) | PMID:34935315 (animal_model: Nf1Prx1-/-)"
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,2013,British journal of cancer,,,HEK293T cells; SNF96.2,,,,,,,2,1,High,"PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells, SNF96.2) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:29438698 (cell_line: SNF96.2) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:32642733 (cell_line: SNF96.2) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35511749 (cell_line: SNF96.2) | PMID:35789380 (cell_line: HEK293T cells) | PMID:36322658 (cell_line: SNF96.2) | PMID:38216572 (cell_line: SNF96.2) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells, SNF96.2) | PMID:40025578 (cell_line: SNF96.2) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)"
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",2014,PloS one,Nf1Prx1-/-; Nf1Col1,,,,,,,,,2,2,High,"PMID:21726432 (animal_model: Nf1Prx1-/-) | PMID:24465906 (animal_model: Nf1Col1, Nf1Prx1-/-) | PMID:34935315 (animal_model: Nf1Prx1-/-)"
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,2014,PloS one,Nf2flox/flox,,Nf2-deficient spinal cord neural progenitor cells,,,,,,,2,2,High,PMID:17924978 (animal_model: Nf2flox/flox) | PMID:24817309 (animal_model: Nf2flox/flox; cell_line: Nf2-deficient spinal cord neural progenitor cells) | PMID:38945076 (animal_model: Nf2flox/flox) | PMID:41444363 (animal_model: Nf2flox/flox)
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,2015,Cell reports,Nf1 flox/flox; Nf1+/− GFAP CKO,,,,,,,,Nf1+/-,2,2,High,"PMID:19191334 (animal_model: Nf1 flox/flox, Nf1+/− GFAP CKO) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:21963652 (animal_model: Nf1+/− GFAP CKO) | PMID:23225063 (animal_model: Nf1+/− GFAP CKO) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox, Nf1+/− GFAP CKO) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,2016,Cell reports,Nf1fl/fl;DhhCre; Stat3(fl/fl);Nf1(fl/fl);DhhCre,,,,,,,,,2,2,High,"PMID:19191334 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:20200958 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:21439418 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:25535838 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:25772366 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:26904939 (animal_model: Stat3(fl/fl)) | PMID:28525381 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:29787563 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:29847659 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:34935315 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:36322658 (animal_model: DhhCre, DhhCre) | PMID:36890585 (animal_model: Nf1(fl/fl), Nf1fl/fl) | PMID:40684195 (animal_model: Nf1(fl/fl), Nf1fl/fl)"
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,2018,Investigative ophthalmology & visual science,Nf1 flox/flox,neurofibromin,,,,,,,Nf1+/-,2,2,High,PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29438698 (antibody: neurofibromin) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox; antibody: neurofibromin) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36241865 (antibody: neurofibromin) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:37446790 (antibody: neurofibromin) | PMID:38216123 (antibody: neurofibromin) | PMID:38481529 (antibody: neurofibromin) | PMID:39890807 (antibody: neurofibromin) | PMID:40684195 (animal_model: Nf1 flox/flox)
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,2018,BMC research notes,,,S462; T265,,,,,,,2,2,High,"PMID:18483311 (cell_line: S462) | PMID:20049725 (cell_line: S462) | PMID:23328114 (cell_line: S462) | PMID:23535903 (cell_line: S462, T265) | PMID:23685747 (cell_line: S462, T265) | PMID:24681606 (cell_line: S462, T265) | PMID:30055648 (cell_line: S462, T265) | PMID:32383545 (cell_line: S462) | PMID:32642733 (cell_line: S462) | PMID:32948135 (cell_line: S462, T265) | PMID:33658640 (cell_line: S462) | PMID:35511749 (cell_line: S462) | PMID:36322658 (cell_line: T265) | PMID:37164978 (cell_line: S462, T265) | PMID:37410426 (cell_line: S462) | PMID:38127282 (cell_line: S462) | PMID:38203448 (cell_line: T265) | PMID:38502231 (cell_line: S462) | PMID:41001593 (cell_line: S462, T265) | PMID:41022755 (cell_line: S462)"
PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,2018,Nature communications,PLP CreERT2; Nf1 f/−; ROSA-LacZ,NF1,,,,,,,,2,2,High,"PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:30479396 (animal_model: Nf1 f/−, PLP CreERT2, ROSA-LacZ; antibody: NF1) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:38714355 (antibody: NF1) | PMID:39129390 (antibody: NF1) | PMID:39472976 (antibody: NF1) | PMID:41022755 (antibody: NF1) | PMID:41564118 (antibody: NF1)"
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",2019,Nature protocols,,,murine NF2 −/− Schwann cell line; HEI-193,,,,,,,2,2,High,"PMID:21111000 (cell_line: HEI-193) | PMID:30274821 (cell_line: HEI-193) | PMID:30617350 (cell_line: HEI-193, murine NF2 −/− Schwann cell line) | PMID:38216587 (cell_line: HEI-193)"
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,2019,Science signaling,,Merlin,HEK293T cells,,,,,,,2,1,High,PMID:20195187 (antibody: Merlin) | PMID:20554030 (cell_line: HEK293T cells) | PMID:21072183 (antibody: Merlin) | PMID:23175151 (cell_line: HEK293T cells) | PMID:24595234 (antibody: Merlin) | PMID:28126595 (antibody: Merlin) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:29715273 (antibody: Merlin) | PMID:30274821 (antibody: Merlin) | PMID:31015291 (antibody: Merlin; cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:32457840 (antibody: Merlin) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38216587 (cell_line: HEK293T cells) | PMID:38945076 (antibody: Merlin) | PMID:39269317 (cell_line: HEK293T cells) | PMID:39415595 (antibody: Merlin) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,2021,The Laryngoscope,Postn-cre;Nf2f/f,,Primary human vestibular schwannoma (VS) cell cultures,,,,,,,2,2,High,PMID:31527226 (animal_model: Postn-cre) | PMID:32438526 (animal_model: Nf2f/f; cell_line: Primary human vestibular schwannoma (VS) cell cultures) | PMID:33442015 (animal_model: Postn-cre) | PMID:33658640 (animal_model: Postn-cre) | PMID:38127282 (animal_model: Postn-cre)
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,2020,Neuro-oncology advances,C57BL6/J Nf1+/−;Trp53+/−,,NPcis cell line,,,,,,,2,2,High,"PMID:32642734 (animal_model: C57BL6/J Nf1+/−, Trp53+/−; cell_line: NPcis cell line)"
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,2021,Nature medicine,Nf1flox/flox;PostnCre,,ipNF95.6,,,,,,,2,2,High,PMID:19191334 (animal_model: Nf1flox/flox) | PMID:20200958 (animal_model: Nf1flox/flox) | PMID:21439418 (animal_model: Nf1flox/flox) | PMID:25535838 (animal_model: Nf1flox/flox) | PMID:25772366 (animal_model: Nf1flox/flox) | PMID:28525381 (animal_model: Nf1flox/flox) | PMID:29787563 (animal_model: Nf1flox/flox) | PMID:29847659 (animal_model: Nf1flox/flox) | PMID:31527226 (animal_model: PostnCre) | PMID:33442015 (animal_model: PostnCre; cell_line: ipNF95.6) | PMID:33658640 (animal_model: PostnCre) | PMID:33934112 (cell_line: ipNF95.6) | PMID:34935315 (animal_model: Nf1flox/flox) | PMID:35741605 (cell_line: ipNF95.6) | PMID:36890585 (animal_model: Nf1flox/flox) | PMID:38127282 (animal_model: PostnCre) | PMID:38136356 (cell_line: ipNF95.6) | PMID:40684195 (animal_model: Nf1flox/flox)
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,2021,Journal of biomedical optics,Nf1 flox/flox; Nf1Prx1-/-,,,,,,,,,2,2,High,"PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:21726432 (animal_model: Nf1Prx1-/-) | PMID:24465906 (animal_model: Nf1Prx1-/-) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox, Nf1Prx1-/-) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,2022,Cell death and differentiation,,,cis MPNST cell line,NF1-GRD,,,,,,2,2,High,PMID:16835260 (genetic_reagent: NF1-GRD) | PMID:24509877 (genetic_reagent: NF1-GRD) | PMID:35393510 (cell_line: cis MPNST cell line; genetic_reagent: NF1-GRD) | PMID:38000020 (genetic_reagent: NF1-GRD) | PMID:38502231 (cell_line: cis MPNST cell line)
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,2022,Molecular therapy. Nucleic acids,,,HeLa cells; NF2 primary fibroblasts,,,,,,,2,1,High,"PMID:32383545 (cell_line: HeLa cells) | PMID:36420221 (cell_line: HeLa cells, NF2 primary fibroblasts) | PMID:40590220 (cell_line: HeLa cells)"
PMID:38744290,10.1016/j.crmeth.2024.100772,A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.,2024,Cell reports methods,,,,,,cNF organoids,Cutaneous neurofibroma samples,,,2,1,High,PMID:38744290 (advanced_cellular_model: cNF organoids; patient_derived_model: Cutaneous neurofibroma samples)
PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,2024,Redox biology,Nf2flox/flox,Merlin,,,,,,,,2,2,High,PMID:17924978 (animal_model: Nf2flox/flox) | PMID:20195187 (antibody: Merlin) | PMID:21072183 (antibody: Merlin) | PMID:24595234 (antibody: Merlin) | PMID:24817309 (animal_model: Nf2flox/flox) | PMID:28126595 (antibody: Merlin) | PMID:29715273 (antibody: Merlin) | PMID:30274821 (antibody: Merlin) | PMID:31015291 (antibody: Merlin) | PMID:32457840 (antibody: Merlin) | PMID:38945076 (animal_model: Nf2flox/flox; antibody: Merlin) | PMID:39415595 (antibody: Merlin) | PMID:41444363 (animal_model: Nf2flox/flox)
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,2025,Scientific reports,Postn-Cre; Nf2flox/flox; Nf2flox/flox,,,,,,,,,2,2,High,"PMID:17924978 (animal_model: Nf2flox/flox, Nf2flox/flox) | PMID:24817309 (animal_model: Nf2flox/flox, Nf2flox/flox) | PMID:31527226 (animal_model: Postn-Cre) | PMID:33442015 (animal_model: Postn-Cre) | PMID:33658640 (animal_model: Postn-Cre) | PMID:38127282 (animal_model: Postn-Cre) | PMID:38945076 (animal_model: Nf2flox/flox, Nf2flox/flox) | PMID:41444363 (animal_model: Nf2flox/flox, Nf2flox/flox)"
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,2004,Journal of biomedicine & biotechnology,,,,,,,human neurofibroma xenografts,,,1,1,High,PMID:15240917 (patient_derived_model: human neurofibroma xenografts)
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,2009,Journal of neuro-oncology,,,,NF2 TET,,,,,,1,1,High,PMID:18974932 (genetic_reagent: NF2 TET)
PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,2011,Journal of neuroscience methods,,,HEI-193,,,,,,,1,1,High,PMID:21111000 (cell_line: HEI-193) | PMID:30274821 (cell_line: HEI-193) | PMID:30617350 (cell_line: HEI-193) | PMID:38216587 (cell_line: HEI-193)
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,2011,Cancer research,,,Nf1-/- mouse embryo fibroblasts,,,,,,Nf1+/-,1,1,High,PMID:21199799 (cell_line: Nf1-/- mouse embryo fibroblasts)
PMID:21551250,10.1158/0008-5472.CAN-10-4577,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,2011,Cancer research,Nf1 flox,,,,,,,,,1,1,High,PMID:18242513 (animal_model: Nf1 flox) | PMID:21551250 (animal_model: Nf1 flox) | PMID:21681782 (animal_model: Nf1 flox) | PMID:21726432 (animal_model: Nf1 flox) | PMID:32839340 (animal_model: Nf1 flox) | PMID:33078583 (animal_model: Nf1 flox)
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,2011,Experimental neurology,Nf1+/− GFAP CKO,,,,,,,,,1,1,High,PMID:19191334 (animal_model: Nf1+/− GFAP CKO) | PMID:21963652 (animal_model: Nf1+/− GFAP CKO) | PMID:23225063 (animal_model: Nf1+/− GFAP CKO) | PMID:25772366 (animal_model: Nf1+/− GFAP CKO)
PMID:23225063,10.1002/ana.23793,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,2013,Annals of neurology,Nf1+/− GFAP CKO,,,,,,,,,1,1,High,PMID:19191334 (animal_model: Nf1+/− GFAP CKO) | PMID:21963652 (animal_model: Nf1+/− GFAP CKO) | PMID:23225063 (animal_model: Nf1+/− GFAP CKO) | PMID:25772366 (animal_model: Nf1+/− GFAP CKO)
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,2014,Cancer research,Nf2+/-,,,,,,,,,1,1,High,PMID:24371224 (animal_model: Nf2+/-)
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,2014,Annals of neurology,Nf1flox/mut;GFAP-Cre,,,,,,,,,1,1,High,PMID:20554030 (animal_model: Nf1flox/mut) | PMID:25535838 (animal_model: GFAP-Cre)
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,2014,PLoS genetics,,,lymphoblastoid cell lines,,,,,,,1,1,High,PMID:25329635 (cell_line: lymphoblastoid cell lines)
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,2014,PloS one,,,PNF-derived Schwann cells,,,,,,,1,1,High,PMID:25340526 (cell_line: PNF-derived Schwann cells)
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,2015,Molecular psychiatry,9a−/9a− Nf1,,,,,,,,,1,1,High,PMID:25917366 (animal_model: 9a−/9a− Nf1)
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,2016,Journal of proteomics,Nf1 flox/flox; GFAP-Cre,,,,,,,,,1,1,High,"PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: GFAP-Cre, Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)"
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,2016,Genes,,,,NF1 capture probes,,,,,,1,1,High,PMID:27999334 (genetic_reagent: NF1 capture probes)
PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,2016,The New England journal of medicine,DhhCre;Nf1fl/fl,,,,,,,,,1,1,High,PMID:19191334 (animal_model: Nf1fl/fl) | PMID:20200958 (animal_model: Nf1fl/fl) | PMID:21439418 (animal_model: Nf1fl/fl) | PMID:25535838 (animal_model: Nf1fl/fl) | PMID:25772366 (animal_model: Nf1fl/fl) | PMID:28525381 (animal_model: Nf1fl/fl) | PMID:29787563 (animal_model: Nf1fl/fl) | PMID:29847659 (animal_model: Nf1fl/fl) | PMID:34935315 (animal_model: Nf1fl/fl) | PMID:36322658 (animal_model: DhhCre) | PMID:36890585 (animal_model: Nf1fl/fl) | PMID:40684195 (animal_model: Nf1fl/fl)
PMID:28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,2017,Health and quality of life outcomes,,,,,,,,Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire,,1,1,High,PMID:28193237 (clinical_assessment_tool: Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire)
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,2017,Scientific reports,Nf1fl/fl;DhhCre,,,,,,,,,1,1,High,PMID:19191334 (animal_model: Nf1fl/fl) | PMID:20200958 (animal_model: Nf1fl/fl) | PMID:21439418 (animal_model: Nf1fl/fl) | PMID:25535838 (animal_model: Nf1fl/fl) | PMID:25772366 (animal_model: Nf1fl/fl) | PMID:28525381 (animal_model: Nf1fl/fl) | PMID:29787563 (animal_model: Nf1fl/fl) | PMID:29847659 (animal_model: Nf1fl/fl) | PMID:34935315 (animal_model: Nf1fl/fl) | PMID:36322658 (animal_model: DhhCre) | PMID:36890585 (animal_model: Nf1fl/fl) | PMID:40684195 (animal_model: Nf1fl/fl)
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,2018,Neuroscience,P0SchΔ39-121,,,,,,,,,1,1,High,PMID:29408605 (animal_model: P0SchΔ39-121)
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,2018,Scientific reports,,,,Nf1,,,,,,1,1,High,PMID:29670214 (genetic_reagent: Nf1) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (genetic_reagent: Nf1) | PMID:38481529 (genetic_reagent: Nf1) | PMID:39890807 (genetic_reagent: Nf1)
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,2018,PloS one,Nf1 flox/flox,,,,,,,,,1,1,High,PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,2018,PloS one,Nf1Dsk9/+,,,,,,,,,1,1,High,PMID:30571760 (animal_model: Nf1Dsk9/+)
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",2019,Molecular cancer therapeutics,Nf1flox/flox;PostnCre,,,,,,,,,1,1,High,PMID:19191334 (animal_model: Nf1flox/flox) | PMID:20200958 (animal_model: Nf1flox/flox) | PMID:21439418 (animal_model: Nf1flox/flox) | PMID:25535838 (animal_model: Nf1flox/flox) | PMID:25772366 (animal_model: Nf1flox/flox) | PMID:28525381 (animal_model: Nf1flox/flox) | PMID:29787563 (animal_model: Nf1flox/flox) | PMID:29847659 (animal_model: Nf1flox/flox) | PMID:31527226 (animal_model: PostnCre) | PMID:33442015 (animal_model: PostnCre) | PMID:33658640 (animal_model: PostnCre) | PMID:34935315 (animal_model: Nf1flox/flox) | PMID:36890585 (animal_model: Nf1flox/flox) | PMID:38127282 (animal_model: PostnCre) | PMID:40684195 (animal_model: Nf1flox/flox)
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,2019,eLife,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,,,,,,,,,1,1,High,PMID:31545171 (animal_model: 129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+)
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,2020,Nature communications,,,,Nf1,,,,,,1,1,High,PMID:29670214 (genetic_reagent: Nf1) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (genetic_reagent: Nf1) | PMID:38481529 (genetic_reagent: Nf1) | PMID:39890807 (genetic_reagent: Nf1)
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,2020,Proceedings of the National Academy of Sciences of the United States of America,Nf1 flox,,,,,,,,,1,1,High,PMID:18242513 (animal_model: Nf1 flox) | PMID:21551250 (animal_model: Nf1 flox) | PMID:21681782 (animal_model: Nf1 flox) | PMID:21726432 (animal_model: Nf1 flox) | PMID:32839340 (animal_model: Nf1 flox) | PMID:33078583 (animal_model: Nf1 flox)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,2020,"Journal of cachexia, sarcopenia and muscle",Nf1 flox,,,,,,,,,1,1,High,PMID:18242513 (animal_model: Nf1 flox) | PMID:21551250 (animal_model: Nf1 flox) | PMID:21681782 (animal_model: Nf1 flox) | PMID:21726432 (animal_model: Nf1 flox) | PMID:32839340 (animal_model: Nf1 flox) | PMID:33078583 (animal_model: Nf1 flox)
PMID:33085177,10.1002/mgg3.1530,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,2020,Molecular genetics & genomic medicine,,,,,,,,PlexiQoL,,1,1,High,PMID:33085177 (clinical_assessment_tool: PlexiQoL) | PMID:38499890 (clinical_assessment_tool: PlexiQoL)
PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,2021,Neuro-oncology advances,NF1 R1947X minipig,,,,,,,,,1,1,High,PMID:33978635 (animal_model: NF1 R1947X minipig)
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,2021,Nature communications,,NF1,,,,,,,,1,1,High,PMID:25535838 (antibody: NF1) | PMID:28166733 (antibody: NF1) | PMID:30479396 (antibody: NF1) | PMID:34011935 (antibody: NF1) | PMID:34257279 (antibody: NF1) | PMID:38714355 (antibody: NF1) | PMID:39129390 (antibody: NF1) | PMID:39472976 (antibody: NF1) | PMID:41022755 (antibody: NF1) | PMID:41564118 (antibody: NF1)
PMID:34646065,10.1155/2021/9386823,Survival and ,2021,Sarcoma,,,,Nf1,,,,,,1,1,High,PMID:29670214 (genetic_reagent: Nf1) | PMID:32461556 (genetic_reagent: Nf1) | PMID:34011935 (genetic_reagent: Nf1) | PMID:34646065 (genetic_reagent: Nf1) | PMID:36241865 (genetic_reagent: Nf1) | PMID:37140985 (genetic_reagent: Nf1) | PMID:37446790 (genetic_reagent: Nf1) | PMID:38481529 (genetic_reagent: Nf1) | PMID:39890807 (genetic_reagent: Nf1)
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,2023,Acta neuropathologica communications,Nf1 flox/flox,,,,,,,,Nf1+/-,1,1,High,PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,2023,Neuro-oncology,,,ST88-14,,,,,,,1,1,High,PMID:18367665 (cell_line: ST88-14) | PMID:18413802 (cell_line: ST88-14) | PMID:18483311 (cell_line: ST88-14) | PMID:20049725 (cell_line: ST88-14) | PMID:23535903 (cell_line: ST88-14) | PMID:23685747 (cell_line: ST88-14) | PMID:24681606 (cell_line: ST88-14) | PMID:24824755 (cell_line: ST88-14) | PMID:32642733 (cell_line: ST88-14) | PMID:33032988 (cell_line: ST88-14) | PMID:33658640 (cell_line: ST88-14) | PMID:37246765 (cell_line: ST88-14) | PMID:38127282 (cell_line: ST88-14) | PMID:38201517 (cell_line: ST88-14) | PMID:38203448 (cell_line: ST88-14) | PMID:38216572 (cell_line: ST88-14) | PMID:39129390 (cell_line: ST88-14) | PMID:39269317 (cell_line: ST88-14) | PMID:41022755 (cell_line: ST88-14) | PMID:41036607 (cell_line: ST88-14)
PMID:38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,2024,JCI insight,,,NF1-/- iPSC-derived neural crest cells,,,,,,,1,1,High,PMID:38175707 (cell_line: NF1-/- iPSC-derived neural crest cells)
PMID:38499890,10.1186/s41687-024-00714-y,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",2024,Journal of patient-reported outcomes,,,,,,,,PlexiQoL,,1,1,High,PMID:33085177 (clinical_assessment_tool: PlexiQoL) | PMID:38499890 (clinical_assessment_tool: PlexiQoL)
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,2024,Journal of patient-reported outcomes,,,,,,,,cNF-Skindex,,1,1,High,PMID:38811427 (clinical_assessment_tool: cNF-Skindex)
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,2024,"Pharmaceuticals (Basel, Switzerland)","Trp53, Nf1, Suz12 triple mutant",,,,,,,,,1,1,High,"PMID:38931352 (animal_model: Trp53, Nf1, Suz12 triple mutant)"
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,2025,Acta neuropathologica communications,Nf1 flox/flox,,,,,,,,Nf1+/-,1,1,High,PMID:19191334 (animal_model: Nf1 flox/flox) | PMID:20200958 (animal_model: Nf1 flox/flox) | PMID:21439418 (animal_model: Nf1 flox/flox) | PMID:25535838 (animal_model: Nf1 flox/flox) | PMID:25772366 (animal_model: Nf1 flox/flox) | PMID:28525381 (animal_model: Nf1 flox/flox) | PMID:29787563 (animal_model: Nf1 flox/flox) | PMID:29847659 (animal_model: Nf1 flox/flox) | PMID:34935315 (animal_model: Nf1 flox/flox) | PMID:36890585 (animal_model: Nf1 flox/flox) | PMID:40684195 (animal_model: Nf1 flox/flox)
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,2025,JMIR human factors,,,,,,,,Likert scale questionnaire,,1,1,High,PMID:40737523 (clinical_assessment_tool: Likert scale questionnaire)
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,2025,Human genomics,,,,,RENOVO-NF1,,,,,1,1,High,PMID:40887659 (computational_tool: RENOVO-NF1)
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,2023,Human mutation,,,HEK293T cells; COS-7,SPRED1,,,,,,3,0,Medium,"PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: COS-7, HEK293T cells; genetic_reagent: SPRED1) | PMID:40590220 (cell_line: HEK293T cells)"
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,2009,"Experimental biology and medicine (Maywood, N.J.)",,NF2/merlin,DH5α bacteria,,,,,,,2,1,Medium,PMID:19144871 (antibody: NF2/merlin; cell_line: DH5α bacteria) | PMID:33273014 (antibody: NF2/merlin) | PMID:38216572 (antibody: NF2/merlin)
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,2017,Biomolecular NMR assignments,,,BL21(DE3) Star,Spred1(EVH1),,,,,,2,0,Medium,PMID:28831766 (cell_line: BL21(DE3) Star; genetic_reagent: Spred1(EVH1))
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,2008,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",,,,,,,vestibular schwannoma xenografts,,,1,0,Medium,PMID:18636037 (patient_derived_model: vestibular schwannoma xenografts)
PMID:34106871,10.1109/JBHI.2021.3087735,DINs: Deep Interactive Networks for Neurofibroma Segmentation in Neurofibromatosis Type 1 on Whole-Body MRI.,2022,IEEE journal of biomedical and health informatics,,,,,DINs (Deep Interactive Networks),,,,,1,1,Medium,PMID:34106871 (computational_tool: DINs (Deep Interactive Networks))
PMID:28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,2018,Experimental neurology,,,mouse embryonic fibroblasts (MEFs); tail-tip fibroblasts (TTFs),,,,,,,2,0,Low,"PMID:28392281 (cell_line: mouse embryonic fibroblasts (MEFs), tail-tip fibroblasts (TTFs)) | PMID:34065204 (cell_line: mouse embryonic fibroblasts (MEFs))"
PMID:30531922,10.1038/s41591-018-0263-8,The molecular landscape of glioma in patients with Neurofibromatosis 1.,2019,Nature medicine,,,HEK293 cells; U2OS,,,,,,,2,0,Low,"PMID:30531922 (cell_line: HEK293 cells, U2OS) | PMID:33673681 (cell_line: HEK293 cells)"
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,2002,BMC genomics,,,TOP-10F' cells,,,,,,,1,0,Low,PMID:12057013 (cell_line: TOP-10F' cells)
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,2018,Scientific reports,,,HEK293T cells,,,,,,,1,0,Low,PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)
PMID:32419643,10.1177/1533033820919759,Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.,2020,Technology in cancer research & treatment,,,U251,,,,,,,1,0,Low,PMID:25043298 (cell_line: U251) | PMID:32419643 (cell_line: U251) | PMID:33934112 (cell_line: U251)
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,2021,Cancers,,,HEK293 cells,,,,,,,1,0,Low,PMID:30531922 (cell_line: HEK293 cells) | PMID:33673681 (cell_line: HEK293 cells)
PMID:34065204,10.3390/ijms22105367,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,2021,International journal of molecular sciences,,,mouse embryonic fibroblasts (MEFs),,,,,,,1,0,Low,PMID:28392281 (cell_line: mouse embryonic fibroblasts (MEFs)) | PMID:34065204 (cell_line: mouse embryonic fibroblasts (MEFs))
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,2021,Glia,,,HEK293T cells,,,,,,,1,0,Low,PMID:20554030 (cell_line: HEK293T cells) | PMID:23175151 (cell_line: HEK293T cells) | PMID:28166733 (cell_line: HEK293T cells) | PMID:29402968 (cell_line: HEK293T cells) | PMID:31015291 (cell_line: HEK293T cells) | PMID:31836666 (cell_line: HEK293T cells) | PMID:33934112 (cell_line: HEK293T cells) | PMID:34415582 (cell_line: HEK293T cells) | PMID:35789380 (cell_line: HEK293T cells) | PMID:38216587 (cell_line: HEK293T cells) | PMID:39269317 (cell_line: HEK293T cells) | PMID:40225167 (cell_line: HEK293T cells) | PMID:40590220 (cell_line: HEK293T cells)
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,2021,Frontiers in genetics,,,LLC-PK1 ATCC CL-101,,,,,,,1,0,Low,PMID:34630515 (cell_line: LLC-PK1 ATCC CL-101)
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,2025,Cancers,,,MCF7,,,,,,,1,0,Low,PMID:38216123 (cell_line: MCF7) | PMID:40507334 (cell_line: MCF7)
PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,2008,JAMA,,,,,,,,,Nf1+/-,0,0,Low,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,2010,Translational neuroscience,,,,,,,,,Nf1+/-,0,0,Low,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,2012,Cancer research,,,,,,,,,Nf1+/-,0,0,Low,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",2015,Frontiers in cellular neuroscience,,,,,,,,,Nf1+/-,0,0,Low,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,2021,Translational research : the journal of laboratory and clinical medicine,,,,,,,,,Nf1+/-,0,0,Low,
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,1995,"Development (Cambridge, England)",,,,,,,,,Nf1+/-,0,0,Low,
